Cargando…
Mitochondrial hyperactivity as a potential therapeutic target in Parkinson’s disease
Mitochondrial dysfunction is thought to contribute to neurodegeneration in Parkinson’s disease (PD), yet the cellular events that lead to mitochondrial disruption remain unclear. Post-mortem studies of PD patient brains and the use of complex I inhibitors to model the disease previously suggested a...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653964/ https://www.ncbi.nlm.nih.gov/pubmed/33178902 http://dx.doi.org/10.1016/j.tma.2020.07.007 |